Annexon Shares Surge 9% as Biotech Firm Reports 2025 Financial Results
Annexon Inc. stock saw a solid bump recently, with shares jumping nearly 9.4% to hit $5.42 on the NASDAQ. Trading under the ticker ANNX, the clinical-stage biopharmaceutical company now boasts a market cap of roughly…